Suppression of HIV in the first 12 months of antiretroviral therapy: a comparative analysis of dolutegravir- and efavirenz-based regimens

OBJECTIVE: To compare viral suppression in treatment-naïve adults starting antiretroviral therapy with dolutegravir (50mg)- and efavirenz (600mg)-based regimens. METHODS: We analyzed secondary data from Brazilian health information systems of people living with human immunodeficiency virus who start...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva, Gabriella Jomara, Mendicino, Cássia Cristina Pinto, de Pádua, Cristiane Aparecida Menezes, Tupinambás, Unaí
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219625/
https://www.ncbi.nlm.nih.gov/pubmed/37255057
http://dx.doi.org/10.31744/einstein_journal/2023AO0156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219625/
https://www.ncbi.nlm.nih.gov/pubmed/37255057
http://dx.doi.org/10.31744/einstein_journal/2023AO0156

Ejemplares similares